{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:52:55Z","timestamp":1789771975788,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872365"],"award-info":[{"award-number":["81872365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clbc.2024.01.014","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T14:31:02Z","timestamp":1706279462000},"page":"e244-e257.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK\/STAT3 Signaling"],"prefix":"10.1016","volume":"24","author":[{"given":"Zhaohui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clbc.2024.01.014_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clbc.2024.01.014_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12011-017-1207-8","article-title":"Magnesium in breast cancer: what is its influence on the progression of this disease?","volume":"184","author":"Mendes","year":"2018","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0003","first-page":"73","article-title":"Established breast cancer risk factors and risk of intrinsic tumor subtypes","volume":"1856","author":"Barnard","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clbc.2024.01.014_bib0004","article-title":"Diagnostic and prognostic nomograms for lung metastasis in triple-negative breast cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12935-022-02665-0","article-title":"Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer","volume":"22","author":"Bakherad","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.clbc.2024.01.014_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.clbc.2024.01.014_bib0008","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.molonc.2015.10.003","article-title":"Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells","volume":"9","author":"Quigley","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2024.01.014_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2017.04.007","article-title":"Cancer cell and macrophage cross-talk in the tumor microenvironment","volume":"35","author":"Dehne","year":"2017","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","article-title":"Harnessing tumor-associated macrophages as aids for cancer immunotherapy","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2024.01.014_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.clbc.2024.01.014_bib0012","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.3390\/ijms21124414","article-title":"Immuno-metabolism and microenvironment in cancer: key players for immunotherapy","volume":"21","author":"Giannone","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.clbc.2024.01.014_bib0013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/CAD.0b013e3283139100","article-title":"Agents from amphibians with anticancer properties","volume":"19","author":"Lu","year":"2008","journal-title":"Anticancer Drugs"},{"issue":"22","key":"10.1016\/j.clbc.2024.01.014_bib0014","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1016\/j.bmcl.2007.09.065","article-title":"Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR)","volume":"17","author":"Zhang","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.clbc.2024.01.014_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.797873","article-title":"Cinobufacini Injection inhibits the proliferation of triple-negative breast cancer through the Pin1-TAZ signaling pathway","volume":"13","author":"Kong","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.clbc.2024.01.014_bib0016","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10286020.2011.565746","article-title":"Immunomodulatory effects of cinobufagin isolated from Chan Su on activation and cytokines secretion of immunocyte in vitro","volume":"13","author":"Wang","year":"2011","journal-title":"J Asian Nat Prod Res"},{"key":"10.1016\/j.clbc.2024.01.014_bib0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.micpath.2016.08.036","article-title":"Cinobufagin enhances the protective efficacy of formalin-inactivated Salmonella typhimurium vaccine through Th1 immune response","volume":"99","author":"Wu","year":"2016","journal-title":"Microb Pathog"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-022-01503-5","article-title":"Gene expression predicts dormant metastatic breast cancer cell phenotype","volume":"24","author":"Ren","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"7","key":"10.1016\/j.clbc.2024.01.014_bib0019","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.ajpath.2019.04.007","article-title":"Membrane metalloendopeptidase (MME) suppresses metastasis of esophageal squamous cell carcinoma (ESCC) by inhibiting FAK-RhoA signaling axis","volume":"189","author":"Li","year":"2019","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-022-02348-8","article-title":"Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK\/STAT3 pathway","volume":"41","author":"Sun","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.clbc.2024.01.014_bib0021","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/cancers12051086","article-title":"FAK Inhibition Induces Glioblastoma Cell Senescence-Like State through p62 and p27","volume":"12","author":"Alza","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.clbc.2024.01.014_bib0022","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.18632\/aging.204967","article-title":"Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway","volume":"15","author":"Qi","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clbc.2024.01.014_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jot.2020.04.008","article-title":"Defactinib attenuates osteoarthritis by inhibiting positive feedback loop between H-type vessels and MSCs in subchondral bone","volume":"24","author":"Hu","year":"2020","journal-title":"J Orthop Translat"},{"issue":"8","key":"10.1016\/j.clbc.2024.01.014_bib0024","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/ijc.32270","article-title":"Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression","volume":"145","author":"Arroyo-Crespo","year":"2019","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2024.01.014_bib0025","doi-asserted-by":"crossref","first-page":"R513","DOI":"10.1530\/ERC-16-0218","article-title":"Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer","volume":"23","author":"Ochnik","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clbc.2024.01.014_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.932353","article-title":"RET signaling pathway and RET inhibitors in human cancer","volume":"12","author":"Regua","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2024.01.014_bib0027","doi-asserted-by":"crossref","first-page":"479","DOI":"10.6004\/jnccn.2020.7554","article-title":"Role of immunotherapy in triple-negative breast cancer","volume":"18","author":"Keenan","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.clbc.2024.01.014_bib0028","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/ijo.2022.5385","article-title":"Research progress on immunotherapy in triple\u2011negative breast cancer (Review)","volume":"61","author":"Zhang","year":"2022","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clbc.2024.01.014_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731741","article-title":"Immune Effect of active components of traditional chinese medicine on triple-negative breast cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Pharmacol"},{"issue":"33","key":"10.1016\/j.clbc.2024.01.014_bib0030","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.3748\/wjg.14.5210","article-title":"Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma","volume":"14","author":"Qin","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clbc.2024.01.014_bib0031","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10616-010-9310-0","article-title":"Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action","volume":"62","author":"Jiang","year":"2010","journal-title":"Cytotechnology"},{"key":"10.1016\/j.clbc.2024.01.014_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2754542","article-title":"Treatment of huge hepatocellular carcinoma using cinobufacini injection in transarterial chemoembolization: a retrospective study","volume":"2016","author":"Dong","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"issue":"22","key":"10.1016\/j.clbc.2024.01.014_bib0033","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0034","first-page":"200","article-title":"Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition","volume":"11","author":"Bai","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clbc.2024.01.014_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2016.11.016","article-title":"Cinobufagin induces apoptosis of osteosarcoma cells through inactivation of Notch signaling","volume":"794","author":"Cao","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.clbc.2024.01.014_bib0036","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1159\/000488842","article-title":"Cinobufagin induces apoptosis in osteosarcoma cells via the mitochondria-mediated apoptotic pathway","volume":"46","author":"Dai","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clbc.2024.01.014_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.775602","article-title":"Cinobufagin is a selective anti-cancer agent against tumors with EGFR amplification and PTEN deletion","volume":"12","author":"He","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.clbc.2024.01.014_bib0038","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.intimp.2010.12.007","article-title":"Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor","volume":"11","author":"Qi","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.clbc.2024.01.014_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200961","article-title":"Effects of cinobufagin on the proliferation, migration, and invasion of H1299 lung cancer cells","volume":"20","author":"Sun","year":"2023","journal-title":"Chem Biodivers"},{"issue":"20","key":"10.1016\/j.clbc.2024.01.014_bib0040","doi-asserted-by":"crossref","first-page":"28935","DOI":"10.18632\/oncotarget.7898","article-title":"Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.clbc.2024.01.014_bib0041","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/14786419.2017.1315575","article-title":"Anti-proliferative and pro-apoptotic effects of cinobufagin on human breast cancer MCF-7 cells and its molecular mechanism","volume":"32","author":"Zhu","year":"2018","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.clbc.2024.01.014_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2023.112088","article-title":"Hybrid membrane camouflaged Prussian blue nanoparticles with cinobufagin loading for chemo\/photothermal therapy of colorectal cancer","volume":"232","author":"Luo","year":"2023","journal-title":"Materials & Design"},{"key":"10.1016\/j.clbc.2024.01.014_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122369","article-title":"Biomimetic Prussian blue nanocomplexes for chemo-photothermal treatment of triple-negative breast cancer by enhancing ICD","volume":"303","author":"Long","year":"2023","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.clbc.2024.01.014_bib0044","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3892\/ol.2020.11701","article-title":"Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8","volume":"20","author":"Li","year":"2020","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.clbc.2024.01.014_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273044","article-title":"Triple-negative breast cancer influences a mixed M1\/M2 macrophage phenotype associated with tumor aggressiveness","volume":"17","author":"Pe","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clbc.2024.01.014_bib0046","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:36:09Z","timestamp":1742214969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1526820924000259"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.01.014","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK\/STAT3 Signaling","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}